Literature DB >> 2447384

A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils.

A D Snow1, J Willmer, R Kisilevsky.   

Abstract

Two cationic reagents, Ruthenium red (RR) and Cuprolinic blue (CB), were used to assess the morphologic and structural relationship between sulfated proteoglycans and AA amyloid fibrils in amyloidotic spleen and liver, and in isolated fibril preparations. Amyloidotic tissue fixed in the presence of RR showed RR granules, measuring 15 to 25 nm in diameter, over areas of electrondense fibrils. In isolated fibril preparations, RR granules were specifically localized on amyloid fibrils. Amyloidotic tissue fixed in the presence of CB at 0.1 M and 0.7 M MgCl2 showed both granule and filamentous (50 to 90 nm in length) staining only over areas of amyloid fibrils. This same staining localization was also seen in isolated fibril preparations. The RR and CB granules and filaments, are believed to represent proteoglycan monomers with the glycosaminoglycan chains collapsed onto the protein core. The persistent CB staining at 0.7 M magnesium chloride suggested that highly sulfated proteoglycans were present. The glycosaminoglycan moiety has previously been identified as heparin/heparan sulphate. The intimate structural relationship between sulfated proteoglycans and AA amyloid fibrils, both in situ and in isolated fibril preparations, further suggests that these highly negatively charged molecules may have an important role in the pathogenesis of amyloidosis. Several pathogenetic scenarios are suggested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447384

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  25 in total

1.  Accumulation of pro-apolipoprotein A-II in mouse senile amyloid fibrils.

Authors:  K Higuchi; K Kogishi; J Wang; C Xia; T Chiba; T Matsushita; M Hosokawa
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.

Authors:  Jonathan S Wall; Tina Richey; Alan Stuckey; Robert Donnell; Arie Oosterhof; Toin H van Kuppevelt; Nicole C Smits; Stephen J Kennel
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

3.  In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.

Authors:  Jin-Ping Li; Martha L Escobar Galvis; Feng Gong; Xiao Zhang; Eyal Zcharia; Shula Metzger; Israel Vlodavsky; Robert Kisilevsky; Ulf Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-20       Impact factor: 11.205

Review 4.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

5.  Plant-derived mitochondria-targeting cysteine-rich peptide modulates cellular bioenergetics.

Authors:  Antony Kam; Shining Loo; Bamaprasad Dutta; Siu Kwan Sze; James P Tam
Journal:  J Biol Chem       Date:  2019-01-23       Impact factor: 5.157

6.  The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis.

Authors:  I D Young; J P Willmer; R Kisilevsky
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

7.  Experimental amyloidosis in the hamster: correlation between hamster female protein levels and amyloid deposition.

Authors:  F W Snel; T A Niewold; M L Baltz; P R Hol; A M Van Ederen; M B Pepys; E Gruys
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

Review 8.  The role of novel chitin-like polysaccharides in Alzheimer disease.

Authors:  Rudy J Castellani; George Perry; Mark A Smith
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

9.  A computational approach for identifying the chemical factors involved in the glycosaminoglycans-mediated acceleration of amyloid fibril formation.

Authors:  Elodie Monsellier; Matteo Ramazzotti; Niccolò Taddei; Fabrizio Chiti
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

10.  Proteoglycans in haemodialysis-related amyloidosis.

Authors:  K Ohashi; M Hara; M Yanagishita; R Kawai; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.